If you want to learn more about oncology products marketed by our biopharma business in USA and Canada, please visit emdserono.com/fertility (USA) or emdserono.ca/fertility (Canada).

In case you would like to learn more about the products Merck KGaA, Darmstadt, Germany is marketing, please get in touch with service@emdgroup.com

If you want to learn more about products that are marketed by our biopharma business in USA and Canada, please visit www.emdserono.com (USA) or www.emdserono.ca (Canada). 

These products should only be prescribed by physicians specializing in fertility or reproductive health. Risks include the following events which can be serious: allergic reactions; ovarian hyperstimulation syndrome (OHSS); lung problems, blood clots, and multiple births. For complete product details about a specific fertility drug, please refer to the patient information leaflet (Full Prescribing Information for full disclosure).

The information contained on this page is intended for general reference only and uses the European Patient Information Leaflet for illustrative purposes. Product related information contained herein is subject to local product approval and can therefore vary from country to country. It may refer to a product or indications not yet registered or approved in a given country. For information relevant for your country, please check in with local regulatory authorities. This information should not be used to diagnose, treat, cure or prevent any disease without the advice of your doctor. Please contact your doctor for any medical advice or questions. 
 
US and Canadian Residents should consult EMD Serono Inc. for information on products approved for sale in the United States of America.